Enova International CEO sells 15,305 shares
The sales included 7,391 and 3,758 shares tied to exercised options, plus a separate 4,156-share sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Enova International, Inc. Chief Executive Officer Steven E. Cunningham exercised options on October 27, 2026, for 7,391 shares at $31.98 per share and 3,758 shares at $35.75 per share. He sold 15,305 shares of common stock that day at $172 per share, including sales matching both option exercises and a separate 4,156-share sale. No Rule 10b5-1 plan is reported.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
7 txns
Insider
Cunningham Steven E
Role
Chief Executive Officer
Sold
15,305 shs ($2.63M)
Approx. gross sale proceeds
$2.63M
Approx. exercise cost
$371K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR F1, F2, F3 | 7,391 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR F1, F2, F4 | 3,758 | $0.00 | $0.00 |
| Exercise | Common stock, par value $0.00001 per share | 7,391 | $31.98 | $236K |
| Sale | Common stock, par value $0.00001 per share | 7,391 | $172.00 | $1.27M |
| Exercise | Common stock, par value $0.00001 per share | 3,758 | $35.75 | $134K |
| Sale | Common stock, par value $0.00001 per share | 3,758 | $172.00 | $646K |
| Sale | Common stock, par value $0.00001 per share | 4,156 | $172.00 | $715K |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) with limited SAR — 7,514 contracts (Direct);
Common stock, par value $0.00001 per share — 118,789 shares (Direct)
Footnotes (4)
- F1. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- F2. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
- F3. The options vested in substantially equal one-third increments on each of the following dates: February 3, 2023, February 3, 2024, and February 3, 2025.
- F4. The options vested in substantially equal one-third increments on each of the following dates: February 4, 2023, February 4, 2024, and February 4, 2025.
Key Figures
Shares acquired through option exercise: 7,391 shares
Exercise price: $31.98 per share
Shares acquired through option exercise: 3,758 shares
+3 more
6 metrics
Shares acquired through option exercise
7,391 shares
October 27, 2026 option exercise
Exercise price
$31.98 per share
Option exercise on October 27, 2026
Shares acquired through option exercise
3,758 shares
October 27, 2026 option exercise
Exercise price
$35.75 per share
Option exercise on October 27, 2026
Common shares sold
15,305 shares
October 27, 2026
Sale price
$172 per share
Common shares sold on October 27, 2026
Key Terms
Non-Qualified Stock Option, limited stock appreciation right, Offer Value Per Share, Change in Control
4 terms
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy) with limited SAR"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
limited stock appreciation right financial
"The limited stock appreciation right ("SAR") and employee stock option were granted in tandem."
Change in Control financial
"beginning on the first day following the date that a "Change in Control" of Issuer occurs"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ENVA options did the CEO exercise?
Steven E. Cunningham exercised options for 7,391 shares at $31.98 per share and 3,758 shares at $35.75 per share on October 27, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
